Parameswaran, Neetha
Luo, Liping
Zhang, Lingjun
Chen, Joel
DiFilippo, Frank P.
Androjna, Charlie
Fox, David A.
Ondrejka, Sarah L.
Hsi, Eric D.
Jagadeesh, Deepa
Lindner, Daniel J. http://orcid.org/0000-0002-8296-7703
Lin, Feng http://orcid.org/0000-0002-7202-1447
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA275639)
Article History
Received: 25 January 2023
Revised: 24 July 2023
Accepted: 4 August 2023
First Online: 12 August 2023
Competing interests
: LZ, DAF, and FL have financial interests in AbCon Therapeutics, Inc, a Cleveland Clinic start-up company to commercialize the CD6-ADC technology.